Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2025-09-19 00:00:00 ET · period of report 2025-09-18 · accession 0001193125-25-209387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-19 | 2025-09-18 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $29.17 | -64 | 50.2K | -0.1% | -$1,867 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-18 | S | D | 64 | $29.17 | 50,242 | D | — | — | (F2) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |